Research and Markets: Metabolic Risk for Cardiovascular Disease - Related Mostly to the Increasing Prevalence of Obesity, Metabolic Syndrome and Type 2 Diabetes

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/a2d4c6/metabolic_risk_for) has announced the addition of John Wiley and Sons Ltd's new book "Metabolic Risk for Cardiovascular Disease" to their offering.

The relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes.

This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation. Mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance/diabetes are also addressed, and the importance of interventions that reduce metabolic risk factors and CVD are covered.

Key features:

• Outlines and addresses the metabolic factors and related diseases that contribute to cardiovascular disease (CVD)
• Includes brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation
• Addresses mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance/diabetes
• Covers the importance of interventions that reduce metabolic risk factors and CVD

Key Topics Covered:

1. Insulin Action, Fuel Partitioning, and Body Weight Regulations (Steven Kahn & Kristina M Utzschneider)

2. Lipid and Lipoprotein Metabolism and CVD Risk (Frank Sacks)

3. Tobacco and CVD Risk (C. Barr Taylor)

4. Nutrition and CVD Risk (Alice Lichtenstein)

5. Physical Activity and Cardiovascular Health (William E Kraus & William L Haskell)

6. The obesity Epidemic and CVD Risk (Paul Pointer)

7. Insulin Resistance, the Metabolic Syndrome and CVD Risk (Sidney Smith)

8. Diabetes and CVD Risk (Peter Wilson)

9. Lipid Management and CVD Risk Reduction (Antonio M. Gotto, Jr. & John A Farmer)

10. Obesity Management and CVD Risk Reduction (George Bray)

11. Diabetes Management and CVD Risk Reduction (Jay Skyler)

12. A Healthy Lifestyle and CVD Prevention (Arne Astrup)

Author:

Robert H. Eckel, M.D. Professor of Medicine

• Division of Endocrinology, Metabolism and Diabetes
• Division of Cardiology
• Professor of Physiology and Biophysics
• Charles A. Boettcher II Chair in Atherosclerosis
• Program Director, Adult General Clinical Research Center
• University of Colorado at Denver and Health Sciences Center
• Director Lipid Clinic, University Hospital

Dr. Eckel received both his Bachelor of Sciences in Bacteriology and Medical Doctorate from the University of Cincinnati. He did his Housestaff training in Internal Medicine at the University of Wisconsin Hospitals and from there traveled to Seattle for a senior fellowship in Endocrinology and Metabolism. Dr. Eckel was then appointed as Assistant Professor of Medicine at the University of Colorado School of Medicine where he is now Professor of Medicine and holds the Charles A. Boettcher Endowed Chair in Atherosclerosis. In addition, Dr. Eckel holds a joint appointment in the Department of Physiology and Biophysics and adjunct appointments in the School of Pharmacy, the Department of Integrative Physiology at the University of Colorado at Boulder, and in the Department of Food Science and Human Nutrition at Colorado State University. Dr. Eckel currently directs the campus wide Program in Preventive Cardiology at the University of Colorado at Denver and Health Sciences Center.

Shortly after his arrival in Denver, Dr. Eckel was appointed Associate Program Director of the Adult General Clinical Research Center (GCRC) at the University of Colorado Health Sciences Center (UCHSC). In 1993 he assumed the role of Program Director, a position he continues to hold. Dr. Eckels translational research in lipid and lipoprotein metabolism, insulin action, energy balance and body weight regulation has led to a number of awards, and his presidency of the Western Society for Clinical Investigation, the North American Association for the Study of Obesity, the Association for Patient Oriented Research, and the American Heart Association.

For more information visit http://www.researchandmarkets.com/research/a2d4c6/metabolic_risk_for